Nonlesional atopic dermatitis skin shares similar T‐cell clones with lesional tissues

Background Atopic dermatitis (AD) is characterized by robust immune activation. Various T‐cell subsets, including Th2/Th22 cells, are increased in lesional and nonlesional skin. However, there is conflicting literature on the diversity of the T‐cell receptor (TCR) repertoire in lesional AD, and its...

Full description

Saved in:
Bibliographic Details
Published inAllergy (Copenhagen) Vol. 72; no. 12; pp. 2017 - 2025
Main Authors Brunner, P. M., Emerson, R. O., Tipton, C., Garcet, S., Khattri, S., Coats, I., Krueger, J. G., Guttman‐Yassky, E.
Format Journal Article
LanguageEnglish
Published Denmark Blackwell Publishing Ltd 01.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Atopic dermatitis (AD) is characterized by robust immune activation. Various T‐cell subsets, including Th2/Th22 cells, are increased in lesional and nonlesional skin. However, there is conflicting literature on the diversity of the T‐cell receptor (TCR) repertoire in lesional AD, and its relation to nonlesional skin remains unclear. Methods We performed high‐throughput deep sequencing of the β‐TCR repertoire in 29 lesional and 19 nonlesional AD biopsies, compared to six healthy control and six cutaneous T‐cell lymphoma (CTCL) samples from previously published cohorts. Results While greater T‐cell infiltrates were observed in lesional vs nonlesional AD, TCR repertoire diversity was similar in lesional and nonlesional tissues, and absolute numbers of unique T‐cell clones correlated with respective T‐cell counts. Most (87%) top expanded lesional T‐cell clones were shared with nonlesional tissues, and they were largely maintained after 16 weeks of successful treatment with topical triamcinolone. Nevertheless, both lesional and nonlesional AD showed a highly polyclonal TCR pattern, without evidence of oligoclonal expansion, or a preferred usage of certain V‐β genes in AD skin. Size of the overall T‐cell infiltrate, but not the level of clonality, correlated with mRNA levels of key inflammatory mediators (e.g., IL‐13, CCL17, IL23p19, CXCL10). Conclusion While AD harbors a highly polyclonal T‐cell receptor repertoire, and despite the lack of information on TCR antigen specificity, the sharing of top abundant clones between lesional and nonlesional skin, and their persistence after months of therapy, points to the continuous presence of potentially pathogenic skin resident memory T cells well beyond clinically inflamed lesions.
Bibliography:Funding information
PMB was supported in part by grant # UL1 TR00043 from the National Center for Advancing Translational Sciences NCATS, National Institutes of Health (NIH), and Clinical and Translational Science Award (CTSA) program.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0105-4538
1398-9995
DOI:10.1111/all.13223